Two reports detailed cases of an unusual variant of GuillainBarré syndrome (GBS) associated with the AstraZeneca adenovirus vector COVIDVaccines are the most effective strategy to mitigate the global impact of COVID19 However, vaccine hesitancy is common, particularly among minorities GuillainBarré syndrome (GBS) is the most common autoimmune illness of the peripheral nervous system, occurring at an incidence of 11/100,000 worlGuillainBarré syndrome The first documented COVID19triggered autoimmune neurologic disease More to come with myositis in the offing Neurol Neuroimmunol Neuroinflamm Jun 9;7(5)e781 doi /NXI
Scielo Brasil Guillain Barre Syndrome Associated With Sars Cov 2 Infection A Scoping Review Guillain Barre Syndrome Associated With Sars Cov 2 Infection A Scoping Review
